Department of Neurology, Xiangya Hospital, Central South University, Changsha, China.
National Clinical Research Center for Geriatric Disorders, Central South University, Changsha, China.
Alzheimers Dement. 2024 Oct;20(10):7281-7295. doi: 10.1002/alz.14215. Epub 2024 Sep 10.
Frontotemporal dementia (FTD) is characterized by phenotypic and genetic heterogeneities. However, reports on the large Chinese FTD cohort are lacking.
Two hundred forty-eight patients with FTD were enrolled. All patients and 2010 healthy controls underwent next generation sequencing. Plasma samples were analyzed for glial fibrillary acidic protein (GFAP), α-synuclein (α-syn), neurofilament light chain (NfL), and phosphorylated tau protein 181 (p-tau181).
Gene sequencing identified 48 pathogenic or likely pathogenic mutations in a total of 19.4% of patients with FTD (48/248). The most common mutation was the C9orf72 dynamic mutation (5.2%, 13/248). Significantly increased levels of GFAP, α-syn, NfL, and p-tau181 were detected in patients compared to controls (all p < 0.05). GFAP and α-syn presented better performance for diagnosing FTD.
We investigated the characteristics of phenotypic and genetic spectrum in a large Chinese FTD cohort, and highlighted the utility of plasma biomarkers for diagnosing FTD.
This study used a frontotemporal dementia (FTD) cohort with a large sample size in Asia to update and reveal the clinical and genetic spectrum, and explore the relationship between multiple plasma biomarkers and FTD phenotypes as well as genotypes. We found for the first time that the C9orf72 dynamic mutation frequency ranks first among all mutations, which broke the previous impression that it was rare in Asian patients. Notably, it was the first time the C9orf72 G4C2 repeat expansion had been identified via whole-genome sequencing data, and this was verified using triplet repeat primed polymerase chain reaction (TP-PCR). We analyzed the diagnostic accuracy of four plasma biomarkers (glial fibrillary acidic protein [GFAP], α-synuclein [α-syn], neurofilament light chain [NfL], and phosphorylated tau protein 181 [p-tau181]) at the same time, especially for α-syn being included in the FTD cohort for the first time, and found GFAP and α-syn had the highest diagnostic accuracy for FTD and its varied subtypes.
额颞叶痴呆(FTD)的表型和遗传具有异质性。然而,目前缺乏对大型中国 FTD 队列的研究报告。
纳入 248 例 FTD 患者。所有患者和 2010 例健康对照者均进行下一代测序。分析血浆样本中的神经胶质纤维酸性蛋白(GFAP)、α-突触核蛋白(α-syn)、神经丝轻链(NfL)和磷酸化 tau 蛋白 181(p-tau181)。
基因测序在总共 19.4%(48/248)的 FTD 患者中发现了 48 个致病性或可能致病性突变。最常见的突变为 C9orf72 动态突变(5.2%,13/248)。与对照组相比,患者的 GFAP、α-syn、NfL 和 p-tau181 水平显著升高(均 P<0.05)。GFAP 和 α-syn 对 FTD 的诊断具有更好的效果。
我们调查了一个大型中国 FTD 队列的表型和遗传谱特征,并强调了血浆生物标志物在 FTD 诊断中的应用。
本研究使用亚洲大型 FTD 队列更新并揭示了临床和遗传谱,同时探讨了多种血浆生物标志物与 FTD 表型和基因型之间的关系。我们首次发现,C9orf72 动态突变频率在所有突变中排名第一,这打破了之前亚洲患者中罕见的印象。值得注意的是,这是首次通过全基因组测序数据识别 C9orf72 G4C2 重复扩展,并通过三重复引物聚合酶链反应(TP-PCR)进行验证。我们同时分析了 4 种血浆生物标志物(GFAP、α-syn、NfL 和 p-tau181)的诊断准确性,特别是首次将 α-syn 纳入 FTD 队列,发现 GFAP 和 α-syn 对 FTD 及其不同亚型具有最高的诊断准确性。